Drug Substance. Additional test on batch 01- 402 (residual solvents, TFA and optical rotation) External cost* 07k€ Stability study of batch 01- 402 Internal cost — FTE** [*] 55k€ Retest of reference material Internal cost — FTE** [*] 11k€ Total 73k€ * Subcontracting of Additional test on batch 01- 402 at EXPANSIA + shipment ** FTE rates at [*]€
Appears in 3 contracts
Samples: Pharmaceutical Development Agreement (Radius Health, Inc.), Pharmaceutical Development Agreement (Radius Health, Inc.), Pharmaceutical Development Agreement (Radius Health, Inc.)
Drug Substance. Additional test on batch 01- 402 (residual solvents, TFA and optical rotation) External cost* 07k€ [*]€ Stability study of batch 01- 402 Internal cost — FTE** [*] 55k€ [*]€ Retest of reference material Internal cost — FTE** [*] 11k€ [*]€ Total 73k€ [*]€ * Subcontracting of Additional test on batch 01- 402 at EXPANSIA + shipment ** FTE rates at [*]€
Appears in 2 contracts
Samples: Pharmaceutical Development Agreement (Radius Health, Inc.), Pharmaceutical Development Agreement (Radius Health, Inc.)